Omaveloxolone Clinical Trials
5 recruitingDrug
Phase 12Phase 31
Showing 1–5 of 5 trials
Recruiting
Phase 1
A Study to Learn How the Body Processes BIIB141 (Omaveloxolone) When Taken as a Capsule or as a Tablet Dissolved in Liquid, and to Learn About Its Safety in Healthy Adults Ages 18 to 55
Healthy Volunteer
Biogen70 enrolled1 locationNCT07297199
Recruiting
A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it by Their Own Doctors
Friedreich Ataxia
Biogen300 enrolled14 locationsNCT06623890
Recruiting
Phase 3
A Study to Learn More About the Effects and Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old (BRAVE)
Friedreich Ataxia
Biogen255 enrolled34 locationsNCT06953583
Recruiting
Phase 1
A Study to Find Out How BIIB141 (Omaveloxolone) is Processed in the Body and to Learn More About Its Safety in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old
Friedreich Ataxia
Biogen35 enrolled1 locationNCT06054893
Recruiting
A Study to Learn How BIIB141 (Omaveloxolone) Affects the Health of Participants With Friedrich's Ataxia Who Took it During Pregnancy and/or During Breastfeeding and About the Health of Their Babies
Friedreich Ataxia
Biogen20 enrolled1 locationNCT06628687